Abstract:Introduction: Cardiac hypertrophy is characterized by significant metabolic changes, notably an increase in glycolysis. Histone lactylation, a post-translational modification influenced by the glycolytic state of cells, plays a crucial role in regulating gene transcription. However, the relationship between histone lactylation and cardiac hypertrophy remains unclear. Research Questions: This study aims to elucidate the effects and underlying mechanisms of histone lactylation in the progression of cardiac hypertrophy induced by pressure overload. Methods and Results: We observed an increase in histone lactylation levels in hypertrophic hearts from both humans and mice. To investigate further, male mice underwent transverse aortic constriction (TAC) to induce cardiac hypertrophy, followed by either an intraperitoneal injection of Oxamate (an LDHA inhibitor) to reduce histone lactylation or sodium lactate to increase it. Reducing histone lactylation protected the hearts from TAC-induced hypertrophy and fibrosis, preserving cardiac function, while increased histone lactylation exacerbated cardiac hypertrophy and fibrosis, impairing cardiac function. Cardiomyocyte-specific deletion of LDHA also led to a reduction in cardiac hypertrophy. In vitro experiments showed that inhibiting histone lactylation reduced the expression of hypertrophic markers and the hypertrophic growth of cardiomyocytes stimulated by phenylephrine. Using co-immunoprecipitation, we confirmed that P300 and GCN5 are the transferases mediating histone lactylation in cardiomyocytes. Mechanistic studies using the CUT&Tag technique revealed lactate-dependent histone modification was enriched at the promoter of TGFB2, activating its transcription. Inhibiting cardiac-specific TGFB2 expression through adeno-associated viral delivery of shRNA reduced TAC-induced cardiac hypertrophy. Furthermore, TGFB2 overexpression induced a hypertrophic phenotype in cardiomyocytes and activated the PI3K/AKT/mTOR pathways. This hypertrophic phenotype, induced by TGFB2 overexpression, was suppressed by inhibitors of PI3K or AKT. Conclusion: Our findings reveal a critical role for histone lactylation in the development of pathological cardiac hypertrophy by regulating TGFB2 expression and the PI3K/AKT/mTOR pathway.

Possible Mechanism of GATA4 Inhibiting Myocardin Activity During Cardiac Hypertrophy

The Mechanism of Myocardial Hypertrophy Regulated by the Interaction Between Mhrt and Myocardin.

Inhibition of TRPC1 Prevents Cardiac Hypertrophy Via NF-κB Signaling Pathway in Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Myocardin-Related Transcription Factor-A Induces Cardiomyocyte Hypertrophy

DEC1 represses cardiomyocyte hypertrophy by recruiting PRP19 as an E3 ligase to promote ubiquitination-proteasome-mediated degradation of GATA4

STAT3 Inhibits Myocardin Induced Cardiac Hypertrophy

[Role of GATA-4 in Cardiac Development and Remodeling].

Protein Kinase Cα Inhibits Myocardin-Induced Cardiomyocyte Hypertrophy Through the Promotion of Myocardin Phosphorylation.

GATA4 Regulates ANF Expression Synergistically with Sp1 in a Cardiac Hypertrophy Model

Myocardin Induces Cardiomyocyte Hypertrophy

Mir-9 and NFATc3 Regulate Myocardin in Cardiac Hypertrophy

Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts.

Ca²⁺ Signal-Induced Cardiomyocyte Hypertrophy Through Activation of Myocardin.

NFATc4 and Myocardin Synergistically Up-Regulate the Expression of LTCC Α1c in ET-1-induced Cardiomyocyte Hypertrophy.

Gata4-Mediated Cardiac Hypertrophy Induced by D-Myo-Inositol 1,4,5-Tris-phosphate

Abstract 4134695: the Effect and Mechanism of Histone Lactylation in Pathological Cardiac Hypertrophy Induced by Pressure Overload

Cardiac hypertrophy-specific genes are synergistic activated by myocardin and CREB-binding protein (CBP) p300

Interferon Regulatory Factor 9 Protects Against Cardiac Hypertrophy by Targeting Myocardin

MiR-466h-5p Induces Expression of Myocardin with Complementary Promoter Sequences

Myocardin-related transcription factor A regulates integrin beta 2 transcription to promote macrophage infiltration and cardiac hypertrophy in mice

Kindlin-2 Suppresses Transcription Factor GATA4 Through Interaction with SUV39H1 to Attenuate Hypertrophy